Literature DB >> 17161035

Comparative use of radionuclide stress testing, coronary artery calcium scanning, and noninvasive coronary angiography for diagnostic and prognostic cardiac assessment.

Daniel S Berman1, Leslee J Shaw, Rory Hachamovitch, John D Friedman, Donna M Polk, Sean W Hayes, Louise E J Thomson, Guido Germano, Nathan D Wong, Xingping Kang, Alan Rozanski.   

Abstract

Noninvasive cardiac imaging has undergone a recent resurgence with the development of new approaches for imaging coronary atherosclerosis. Non-contrast computed tomography (CT) for imaging the extent of coronary artery calcification (CAC) and contrast CT for noninvasive coronary angiography (CTA) are developments with a growing evidence base regarding risk assessment and the diagnosis of obstructive coronary disease. This review discusses the role of CAC for risk assessment of asymptomatic individuals and for the use of coronary CTA in symptomatic patients. By comparison, gated myocardial perfusion scintigraphy (MPS) is a well-established noninvasive imaging modality that is a core element in evaluation of patients with stable chest pain syndromes. Stress MPS is the most commonly used stress imaging technique for patients with suspected or known coronary disease. In contrast to the nascent evidence noted with coronary CTA, MPS has a robust evidence base, including the support of numerous clinical guidelines. We highlight the current evidence supporting the diagnostic accuracy and risk stratification data for MPS for symptomatic patients with known or suspected coronary artery disease. It is likely that assessing the extent of atherosclerosis using CAC or coronary CTA will become an increasing part of mainstream cardiovascular imaging practices. In some patients, further ischemia testing with MPS will be required. Similarly, in some patients referred for MPS, anatomic definition of atherosclerosis using CAC by CT may be appropriate. Thus, this review also provides a synopsis of the available literature on imaging that integrates both CT and MPS in combined strategies for the assessment of atherosclerotic and obstructive coronary disease burden. We also propose possible risk-based strategies through which imaging might be used to identifying candidates for more intensive prevention and risk factor modification strategies as well as those who would benefit from referral to coronary angiography and revascularization.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17161035     DOI: 10.1053/j.semnuclmed.2006.08.002

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  18 in total

1.  The prevalence and predictive accuracy of quantitatively defined transient ischemic dilation of the left ventricle on otherwise normal SPECT myocardial perfusion imaging studies.

Authors:  Mohamed A Mandour Ali; Jamieson M Bourque; Adel H Allam; George A Beller; Denny D Watson
Journal:  J Nucl Cardiol       Date:  2011-09-23       Impact factor: 5.952

2.  The potential role for the use of cardiac computed tomography angiography for the acute chest pain patient in the emergency department.

Authors:  Sean R Wilson; James K Min
Journal:  J Nucl Cardiol       Date:  2011-02       Impact factor: 5.952

3.  Underestimation of extent of ischemia by gated SPECT myocardial perfusion imaging in patients with left main coronary artery disease.

Authors:  Daniel S Berman; Xingping Kang; Piotr J Slomka; James Gerlach; Ling de Yang; Sean W Hayes; John D Friedman; Louise E J Thomson; Guido Germano
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

Review 4.  Clinical imaging for prevention: directed strategies for improved detection of presymptomatic patients with undetected atherosclerosis--Part I: Clinical imaging for prevention.

Authors:  Leslee J Shaw; Daniel S Berman; Roger S Blumenthal; Matthew J Budoff; Tracy L Faber; Tauqir Goraya; Sandra S Halliburton; Harvey Hecht; Hosen Kiat; Wolfgang Koenig; Shaista Malik; Michael Merhige; Khurram Nasir; James K Min; James O'Keefe; Donna M Polk; Paolo Raggi; Jeffrey A Rosenblatt; Ronald G Schwartz; Allen J Taylor; Gregory S Thomas; William Wijns
Journal:  J Nucl Cardiol       Date:  2008 Jan-Feb       Impact factor: 5.952

5.  Complementary utility of multislice computed tomographic coronary angiography for detection of high-grade lesions in patients with negative stress myocardial perfusion imaging.

Authors:  Gaurav Gupta; Azam Anwar; Michael D Brophey; Jeffrey M Schussler
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-10

6.  Geometric feature-based multimodal image registration of contrast-enhanced cardiac CT with gated myocardial perfusion SPECT.

Authors:  Jonghye Woo; Piotr J Slomka; Damini Dey; Victor Y Cheng; Byung-Woo Hong; Amit Ramesh; Daniel S Berman; Ronald P Karlsberg; C-C Jay Kuo; Guido Germano
Journal:  Med Phys       Date:  2009-12       Impact factor: 4.071

7.  The role of calcium score and CT angiography in the medical management of patients with normal myocardial perfusion imaging.

Authors:  Gaurav Choudhary; Victor Shin; Shahnaz Punjani; Nathan Ritter; Satish C Sharma; Wen-Chih Wu
Journal:  J Nucl Cardiol       Date:  2010 Jan-Feb       Impact factor: 5.952

8.  The prognostic value of multidetector coronary CT angiography for the prediction of major adverse cardiovascular events: a multicenter observational cohort study.

Authors:  James K Min; J Feignoux; J Treutenaere; T Laperche; J Sablayrolles
Journal:  Int J Cardiovasc Imaging       Date:  2010-03-27       Impact factor: 2.357

9.  Use of coronary calcium scanning for predicting inducible myocardial ischemia: Influence of patients' clinical presentation.

Authors:  Alan Rozanski; Heidi Gransar; Nathan D Wong; Leslee J Shaw; Romalisa Miranda-Peats; Sean W Hayes; John D Friedman; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2007 Sep-Oct       Impact factor: 5.952

10.  Prognostic estimation of coronary artery disease risk with resting perfusion abnormalities and stress ischemia on myocardial perfusion SPECT.

Authors:  Leslee J Shaw; Robert C Hendel; Gary V Heller; Salvador Borges-Neto; Manuel Cerqueira; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2008-09-12       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.